medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2015, Número 6

<< Anterior Siguiente >>

Ann Hepatol 2015; 14 (6)


Prevalence of hepatitis B and C markers in a population of an urban university in Rio de Janeiro, Brazil: a cross-sectional study

Pinto FPD, Ferreira JOC, Olmedo DB, Precioso PM, Barquette FRS, Castilho MC, Silva, SGC, Pôrto LC

Idioma: Ingles.
Referencias bibliográficas: 31
Paginas: 815-825
Archivo PDF: 123.12 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Lee MH, Yang HI, Yuan Y, L’Italien G, Chen CJ. Epidemiology and natural history of hepatitis C virus infection. World J Gastroenterol 2014; 20; 9270-80.

  2. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses; a global overview. Clin Liver Dis 2010; 14; 1-21.

  3. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection; new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57; 1333-42.

  4. Bruggmann P, Berg T, Ovrehus AL, Brandao Mello CE, Roudot- Thoraval F, Marinho RT, Sherman M, et al. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat 2014; 21(Suppl. 1); 5-33.

  5. WHO Fact sheet N°204. Available at: http:// www.who.int/mediacentre/factsheets/fs204/en/

  6. Gerlich WH. Medical virology of hepatitis B; how it began and where we are now. Virol J 2013; 10: 239.

  7. Lavanchy D. Viral hepatitis; global goals for vaccination. J Clin Virol 2012; 55: 296-302.

  8. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014.

  9. Wedemeyer H, Duberg AS, Buti M, Rosenberg WM, Frankova S, Esmat G, Ormeci N, et al. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat 2014; 21: 60-89.

  10. IBGE; Censo Demográfico 2010. Características da População e dos Domicílios. Resultados do Universo. In: Rio de Janeiro; IBGE, 2011.

  11. Ximenes RA, Pereira LM, Martelli CM, Merchan-Hamann E, Stein AT, Figueiredo GM, Braga MC, et al. Methodology of a nationwide cross-sectional survey of prevalence and epidemiological patterns of hepatitis A, B and C infection in Brazil. Cad Saude Publica 2010; 26; 1693-704.

  12. Domingues CMAS, Lins Neto AA, Verotti MP, Burgos Filho R. Ampliação da oferta da vacina de Hepatite B para a faixa etária de 30 a 49 anos em 2013. In: Vigilância das Doenças Transmissíveised. Brazil; Ministério da Saúde, 2013.

  13. Ribeiro JE, Oliveira RSM, Hallal RC. Protocolo clínico e diretrizes terapêuticas para hepatite viral C e coinfecções In; DST, Aids e Hepatites viraised. Brasilia; Minisério da Saúde, 2011.

  14. Carvalho P, Schinoni MI, Andrade J, Vasconcelos Rego MA, Marques P, Meyer R, Araujo A, et al. Hepatitis B virus prevalence and vaccination response in health care workers and students at the Federal University of Bahia, Brazil. Ann Hepatol 2012; 11: 330-7.

  15. de Almeida-Neto C, Sabino EC, Liu J, Blatyta PF, Mendrone- Junior A, Salles NA, Leao SC, et al. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus. Transfusion 2013; 53: 827-34.

  16. Pereira LM, Martelli CM, Merchan-Hamann E, Montarroyos UR, Braga MC, de Lima ML, Cardoso MR, et al. Populationbased multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil. Am J Trop Med Hyg 2009; 81: 240-7.

  17. Tabor E, Gerety RJ, Smalwood LA, Barker LF. Coincident hepatitis B surface antigen and antibodies of different subtypes in human serum. J Immunol 1977; 118: 369-70.

  18. Gerlich WH.The enigma of concurrent hepatitis B surface antigen (HBsAg) and antibodies to HBsAg. Clin Infect Dis 2007; 44: 1170-2.

  19. Lada O, Benhamou Y, Poynard T, Thibault V. Coexistence of Hepatitis B surface antigen (HBsAg) and anti-HBs antibodies in chronic hepatitis B virus carrier: influence of “a” determinant variants. J Virol 2006; 80: 2968-75.

  20. Zhang J-M, Xu Y, Wang X-Y, Wu X-H, Weng X-H, Lu M. Coexistence of Hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Clin Infect Dis 2007; 44: 1161-8.

  21. Minuk GY, Huynh C, Uhanova J, Osiowy C. Establishing diagnostic criteria for occult hepatitis B virus infections in community based populations. J Med Virol 2014; 86: 156-61.

  22. de la Fuente RA, Gutierrez ML, Garcia-Samaniego J, Fernandez- Rodriguez C, Lledo JL, Castellano G. Pathogenesis of occult chronic hepatitis B virus infection. World J Gastroenterol 2011; 17: 1543-8.

  23. Rosini N, Mousse D, Spada C, Treitinger A. Seroprevalence of HbsAg, Anti-HBc and anti-HCV in Southern Brazil, 1999- 2001. Braz J Infect Dis 2003; 7: 262-7.

  24. Lewis-Ximenez LL, do OK, Ginuino CF, Silva JC, Schatzmayr HG, Stuver S, Yoshida CF. Risk factors for hepatitis B virus infection in Rio de Janeiro, Brazil. BMC Public Health 2002; 2: 26.

  25. Pereira LM, Martelli CM, Moreira RC, Merchan-Hamman E, Stein AT, Cardoso MR, Figueiredo GM, et al. Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009; a cross-sectional study. BMC Infect Dis 2013; 13: 60.

  26. Braga WS, Castilho MC, Borges FG, Martinho AC, Rodrigues IS, Azevedo EP, Scazufca M, et al. Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon. Rev Soc Bras Med Trop 2012; 45: 13-7.

  27. Fernandes L, Burnett RJ, Francois G, Mphahlele MJ, Van Sprundel M, De Schryver A. Need for a comprehensive, consistently applied national hepatitis B vaccination policy for healthcare workers in higher educational institutions; a case study from South Africa. J Hosp Infect 2013; 83: 226-31.

  28. Saffar H, Ajami A, Saffar MJ, Shojaei J, Sotudeh-Anvari M, Shams-Esfandabad K, Khalilian AR. Prevalence of hepatitis B virus seromarkers in young adults vaccinated at birth; impact on the epidemiology of hepatitis B infection in Iran. Hepat Mon 2014; 14; e17263.

  29. Amponsah-Dacosta E, Lebelo RL, Rakgole JN, Burnett RJ, Selabe SG, Mphahlele MJ. Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa. J Med Virol 2014; 86: 918-24.

  30. Oliveira SAN, Hacker MA, Oliveira MLA, Yoshida CFT, Telles PR, Bastos FI. A window of opportunity; declining rates of hepatitis B virus infection among injection drug users in Rio de Janeiro, and prospects for targeted hepatitis B vaccination. Rev Panam Salud Publica 2005; 18: 271-7.

  31. Ribeiro JE, Hallal RC. Protocolo Clínico e Diretrizes Terapêuticas para Hepatite Viral C e Coinfecções. Manejo do paciente infectado cronicamente pelo genótipo 1 do HCV e fibrose avançada. In: DST, Aids e Hepatites viraised. Brasília; Ministério da Saúde, 2013.




2020     |     www.medigraphic.com